Helicobacter pylori Eradication: Treatment Guide
Helicobacter pylori eradication refers to the targeted antibiotic-based treatment to completely eliminate the stomach bacterium Helicobacter pylori and prevent related diseases.
Things worth knowing about "Helicobacter pylori Eradication"
Helicobacter pylori eradication refers to the targeted antibiotic-based treatment to completely eliminate the stomach bacterium Helicobacter pylori and prevent related diseases.
What Is Helicobacter pylori Eradication?
Helicobacter pylori eradication is a medical treatment aimed at completely eliminating the bacterium Helicobacter pylori from the stomach and gastrointestinal tract. Helicobacter pylori is a gram-negative bacterium that colonizes the gastric mucosa and can cause a range of digestive disorders. Given its widespread global prevalence, eradication therapy is one of the most commonly performed treatments in gastroenterology.
Causes and Indications
Eradication therapy is recommended when a Helicobacter pylori infection has been confirmed and certain conditions are present or a significant risk of complications exists. Common indications include:
- Gastric ulcer or duodenal ulcer
- Chronic gastritis (type B, H. pylori-associated)
- MALT lymphoma of the stomach
- History of early-stage gastric cancer treatment
- Long-term use of NSAIDs (non-steroidal anti-inflammatory drugs) or aspirin in patients with confirmed H. pylori infection
- Functional dyspepsia with confirmed H. pylori infection
Mechanism of Action and Treatment Regimens
Eradication therapy typically combines several agents to attack the bacterium through different pathways and to overcome antibiotic resistance. The cornerstone of every regimen is a proton pump inhibitor (PPI), which reduces gastric acid production and creates a more favorable environment for antibiotic activity.
Classic Triple Therapy (Standard)
The most commonly used first-line regimen is triple therapy, consisting of:
- A proton pump inhibitor (e.g., omeprazole, pantoprazole)
- Clarithromycin (antibiotic)
- Amoxicillin (antibiotic) or alternatively metronidazole
Treatment typically lasts 7 to 14 days. A 14-day course is increasingly preferred as it achieves higher eradication rates.
Bismuth-Based Quadruple Therapy
In cases of clarithromycin resistance or failure of triple therapy, a quadruple therapy is used, consisting of:
- Proton pump inhibitor
- Bismuth subcitrate or bismuth subsalicylate
- Tetracycline
- Metronidazole
Sequential and Concomitant Therapy
Alternative options include sequential therapy (successive administration of different antibiotics) and concomitant therapy (simultaneous use of four agents without bismuth), particularly recommended in regions with high local resistance rates.
Diagnosis and Monitoring
Before treatment, infection is confirmed using various diagnostic methods:
- Urea breath test (13C-UBT): the non-invasive gold standard for diagnosis and follow-up
- Stool antigen test: detects H. pylori antigens in stool samples
- Upper endoscopy (gastroscopy) with biopsy for culture, histology, or rapid urease test
- Serology: blood test for H. pylori antibodies (less suitable for confirming eradication success)
After completing therapy, treatment success should be confirmed no earlier than 4 weeks after finishing antibiotics, preferably using the urea breath test or stool antigen test.
Side Effects of Therapy
Eradication therapy is generally well tolerated, but side effects may occur:
- Nausea, vomiting, and diarrhea
- Metallic taste in the mouth (especially with metronidazole)
- Disruption of the gut microbiome
- Allergic reactions to antibiotics (especially amoxicillin)
- In rare cases: Clostridioides difficile-associated diarrhea
Treatment Success and Antibiotic Resistance
When therapy is carried out correctly, eradication rates range between 80 and 95 percent. Rising antibiotic resistance, particularly to clarithromycin and metronidazole, represents a growing challenge. Current guidelines recommend considering local resistance patterns when selecting a treatment regimen. If first-line therapy fails, resistance testing should ideally be performed before initiating second-line treatment.
References
- Malfertheiner P. et al. - Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut, 2022. DOI: 10.1136/gutjnl-2022-327745
- Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. - ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology, 2017. DOI: 10.1038/ajg.2016.563
- World Health Organization (WHO) - Helicobacter pylori. Fact Sheet, 2023. Available at: www.who.int
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalorie deficit
Macronutrients
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Helicobacter pylori Eradication-en